Bioinformatic analysis of Aha1 levels from various cancers was performed with data from the Cancer Genome Atlas, wherein the data indicated increased Aha1 activity is associated with colorectal adenocarcinoma (CRC), hepatocellular carcinoma (HCC) and prostate cancer (Mangangcha et al., 2019; Han et al., 2020; Wang et al., 2009). Here, AHSA1 is linked to prostate carcinoma.